-
Company Insights
New![]()
Innovation and Patenting activity of GEA Group AG Q3 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of GEA Group AG Q3 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be...
-
Product Insights
New![]()
Santo Cristo de Magallon
Santo Cristo de Magallon is an Onshore Wind project located in Aragon, Spain. The project is owned by Macquarie European Infrastructure Fund and was developed by GEA Magallon II S.L.. The project came online in 2006. Empower your strategies with our Santo Cristo de Magallon report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends...
-
Product Insights
![]()
GEA Grp – Elsdorf Pharmaceutical Technology Center Development – North Rhine-Westphalia
Equip yourself with the essential tools needed to make informed and profitable decisions with our GEA Grp - Elsdorf Pharmaceutical Technology Center Development - North Rhine-Westphalia report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive...
-
Company Profile
![]()
GEA Group AG – Company Profile
GEA Group AG (GEA) is an engineering group that develops and manufactures process technologies and components. It specializes in machinery, plants, and also process technology and components. GEA provides separators, homogenizers, valves, pumps, and refrigeration equipment. The company offers process technology, feeding systems, dairy equipment, and slurry engineering. It serves customers in beverage, leisure and sport, dairy farming, food, home and personal care, dairy processing, transportation, marine, pharmaceutical, chemical, and utility sectors in Asia Pacific, Latin America, North America, Europe,...
Add to Basket -
Company Profile
![]()
Pargesa Holding SA – Company Profile
Pargesa Holding SA (Pargesa) is an investment holding company. Its main shareholdings include GBL, Imerys SA, Canyon, Voodoo, Adidas, Pernod Ricard SA, SGS SA, Lafarge-Holcim Ltd, Umicore NV/SA, Mqwi, GEA, Ontex, Webhelp, Parques Reunidos and Sienna Capital. The company invests in various industries including minerals processing, oil and gas, energy, health, alcoholic beverages, water and waste management, and building materials. The company offers energy solutions, oil and gas products, chemical solutions, renewable energy, filtration and performance additives products, ceramic materials,...
Add to Basket -
Product Insights
![]()
GEA – Opera House – Ar Riyad
Equip yourself with the essential tools needed to make informed and profitable decisions with our GEA - Opera House - Ar Riyad report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into the GEA...
-
Product Insights
![]()
Likelihood of Approval and Phase Transition Success Rate Model – GEA-001
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry GEA-001 Drug Details GEA-001 is under development for the treatment of coronavirus disease 2019...
-
Product Insights
![]()
Polycystic Ovarian Syndrome Global Clinical Trials Review, H1, 2018
GlobalData's clinical trial report, “Polycystic Ovarian Syndrome Global Clinical Trials Review, H1, 2018" provides an overview of Polycystic Ovarian Syndrome clinical trials scenario. This report provides top line data relating to the clinical trials on Polycystic Ovarian Syndrome. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Track & Monitor
![]()
PharmSource – M&A in the Contract Manufacturing Industry: Implications and Outlook – 2018 Edition
This report is the 2nd edition of our analysis of Mergers and Acquisitions in the contract manufacturing industry. PharmSource is the most definitive, trustworthy source of strategic insight on this topic in the bio/pharmaceutical realm.
-
Sector Analysis
![]()
Refining Industry Outlook in Middle East to 2023 – Capacity and Capital Expenditure Outlook with Details of All Operating and Planned Refineries
Refining Industry Outlook in Middle East to 2023 – Capacity and Capital Expenditure Forecasts with Details of All Operating and Planned Refineries is a comprehensive report on crude oil refining industry in the Middle East. The report provides refinery details such as the refinery name, country, and refinery operator name, with in-depth coverage on crude distillation unit or, CDU capacity and other major unit capacities for all active and new-build (planned and announced) refineries in the region. The report also...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.